pharmaphorum

MAY 16, 2022

Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), tells us what the agency focuses on to strengthen digital health infrastructure globally and improve and expand healthcare access. Digital Strategy and Digital Health Vision.

Development 117

Development Life Science Vaccination Vaccine 117

Drug Discovery World

FEBRUARY 12, 2024

In 2024, we can expect another wave of innovative new drugs to be developed using the technology, given that the AI-fuelled small molecule discovery pipeline is growing by almost 40% annually.” Looking even further into the future, Industry 4.0 Looking even further into the future, Industry 4.0

Genome 139

Genome Genomics Life Science Gene Therapy 139

Drug Discovery World

NOVEMBER 24, 2022

With European life sciences R&D investment at a 20-year low, biopharmaceutical associations and MEPs are calling on the EU to modernise its policies. Fortunately, the EFPIA report also offers a detailed list of recommendations and the hope that with a proactive approach to nurturing life sciences, this trend can be reversed. .

Gene Therapy 98

Gene Therapy Gene Clinical Trials Clinical Trials 98

XTalks

JANUARY 20, 2022

Life science consulting can be a rewarding career and the job outlook is promising for the future. . Perhaps you have heard of life science consulting jobs but do not exactly know what type of work is involved, or the education and experience needed to become a life science consultant.

Life Science 98

Life Science Production Marketing Big Data 98

pharmaphorum

OCTOBER 19, 2022

Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. It’s a must for the industry. Implementing modular content.

Life Science 97

Life Science Compliance Production Pharma Companies 97

pharmaphorum

JULY 16, 2021

Debiopharm Innovation Fund’s Tanja Dowe on investing in digital health start-ups and supporting them on their rollercoaster rides to improve patient outcomes. The weight of expectation hangs heavy over the digital health sector. The post Enabling healthcare’s digital future appeared first on.

Life Science 40

Life Science Engineer 40

pharmaphorum

MAY 6, 2022

For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge. Closing the digital expectation gap in pharma. Combination pricing: access to the future of oncology treatment. Subscribe to future issues of Deep Dive.

Marketing 52

Marketing Life Science Regulation Development 52

pharmaphorum

DECEMBER 9, 2021

If the UK creates regulatory frameworks that drastically diverge from those of its “science allies”, it could become a late – or even no – launch market for new treatments. The vision paper focuses on how to boost the “global competitiveness” of the UK’s life sciences, and make it a “go-to destination for innovation”.

Regulation 98

Regulation Medicine Life Science Development 98

pharmaphorum

JULY 8, 2022

A recent Science 37 survey noted that nearly three-quarters (73%) of respondents from the pharma industry were planning a hybrid or DCT, up from 49% in 2021. Significant opportunities exist for pharma to partner with technologists to leverage digital and sensor technologies to drive further time-and cost-efficiencies in clinical trials.

Clinical Trials 99

Clinical Trials Clinical Trials Trials Regulation 99

Pharmaceutical Technology

OCTOBER 5, 2022

Technology is advancing the possibilities of healthcare treatments, from the development of innovative new drugs to freeing up time for doctors thanks to monitoring devices for patients with conditions such as diabetes and high blood pressure. Moreover, it creates an environment for ongoing innovation and evolution of tools and services.”.

Life Science 130

Life Science Development Medicine Doctors 130

pharmaphorum

NOVEMBER 25, 2021

Now, as face-to-face engagement returns to the agenda, all eyes are on the future shape of pharma events as the world starts to navigate its way out of pandemic conditions. Rethinking pharma’s events’ strategy. A common first step for digital meetings was often to take what was used to occur face-to-face and put it online.

Pharma Companies 98

Pharma Companies Production Sales Marketing 98

pharmaphorum

APRIL 11, 2022

Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. We were really searching for the right investment in this emerging digital space. Exploring the wider impact on digital healthcare.

Clinical Trials 110

Clinical Trials Clinical Trials Trials Development 110

pharmaphorum

JANUARY 26, 2021

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Well, it goes without saying, COVID-19 has resulted in a rapid adoption of digital technologies across all industries, most notably in healthcare.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

Drug Discovery World

OCTOBER 16, 2023

This environment of research excellence, in turn, fosters R&D, innovation, spin-offs, start-ups, networking, collaboration and entrepreneurship, which sets a sturdy foundation that attracts funding, and creates an appealing work culture. Northern Ireland “Northern Ireland is a medtech super-hub,” says Saleko. Government investment of £1.3

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

APRIL 28, 2021

Eric Gilbert explores how data science techniques like text mining are speeding up research into areas such as pancreatic cancer. As a result, many researchers and organisations are relying more on digital technologies and data science techniques to help break down and digest the information available.

Immune Response 105

Immune Response Life Science Genome Genomics 105

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 98

Life Science Pharma Companies Sales Marketing 98

pharmaphorum

OCTOBER 19, 2020

As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data science to overcome increasing pressures on healthcare systems. In the past, our collective adoption of, and trust in, digital technology has been incremental and often reluctant.

Big Data 128

Big Data Production Development Research 128

pharmaphorum

JULY 1, 2021

Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm’s Tanja Dowe. Chemistry, engineering and computer science will have to play together in a much more integrated way than they have to date.

Gene Editing 87

Gene Editing Engineer Development Gene 87

pharmaphorum

AUGUST 31, 2021

For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. Still, in 2021, we have seen the industry evolve and develop strategies on how to establish a viable ECA. Myth 1: There are too many challenges with adopting an ECA. About the authors.

Clinical Trials 89

Clinical Trials Clinical Trials Life Science Trials 89

ACRP blog

SEPTEMBER 11, 2023

Overview Decentralized clinical trials (DCTs) represent the shift towards implementing virtual research studies using digital health tools to gather data and monitor patient activity. The digital divide along socio-economic lines means that not everyone has equal access to high-speed internet. This is a sponsored message. In the U.S.

Clinical Trials 69

Clinical Trials Clinical Trials Trials Drugs 69

pharmaphorum

MAY 18, 2022

While around 70% of epilepsy patients today are well-controlled and largely able to enjoy a ‘normal’ quality of life, either seizure-free or with a much lower frequency of seizures, we are working hard to understand the underlying causes of the symptoms of those remaining 30% who still don’t respond to available therapies,’ explains Charl.

Gene Therapy 92

Gene Therapy Gene Genetics Development 92

XTalks

JULY 10, 2023

In the ever-evolving landscape of healthcare, a groundbreaking innovation has emerged that promises to reshape the way we diagnose, treat, and manage medical conditions. At Huma, we have that opportunity to bring innovation and technology that can flip the focus towards delighting patients. But in healthcare, we don’t.

Life Science 52

Life Science Cardiology Regulation Pharma Companies 52

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. Pre-commercial companies need to hit the ground running with their launch strategies to be successful,” says Ian Hale, vice president of commercial content at Veeva. “Pre-commercial

Production 52

Production Sales Life Science Marketing 52

XTalks

OCTOBER 8, 2020

Aizon hopes that the rebrand will help drive its superior AI and ML-driven analytical platforms to help serve a wide range of industries within the life sciences and food sector. As another recent example, genomics data company Wuxi NextCODE underwent restructuring and has emerged under the new name Genuity Science.

Manufacturing 98

Manufacturing Life Science Cosmetics Regulation 98

pharmaphorum

JANUARY 27, 2023

She knows only too well how understanding the importance of patient centricity is crucial to the success of any modern life sciences company – but how has the landscape changed since 2019? “I I still feel that it is very important,” Dr Mullen said. “We’ve And this ethos is true of Boyds, as well. “I

Clinical Trials 110

Clinical Trials Clinical Trials Trials Development 110

Drug Discovery World

NOVEMBER 1, 2022

Australia’s drug discovery industry shows promise and innovation, as well as business opportunities. The Sector Snapshot 2022 was commissioned by AusBiotech, an Australian industry body representing and advocating for organisations doing business in and with the global life sciences economy 1.

Drugs 52

Drugs Life Science Research Genome 52

pharmaphorum

JUNE 8, 2022

A healthcare consulting firm for more than 20 years, Avalere partners with leading life sciences companies, health plans, providers, and investors to bring innovative, data-driven solutions to complex healthcare challenges. . A technology-enabled partnership . We are delighted to welcome the Avalere team to FH.

Marketing 52

Marketing Life Science Production Regulation 52

pharmaphorum

JANUARY 25, 2022

Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach. “For example, they might want to talk to a nurse, a patient advocate or a digital influencer. . That’s key.

Sales 105

Sales Production Life Science Nurses 105

pharmaphorum

JUNE 11, 2021

Both the breakneck speed and scale of this vaccine generation and distribution were remarkable and encouraging for the future development of treatments for various conditions. These trends combine to increase the pace of innovation and the precision of therapies. Treat them as such. About the author.

Clinical Trials 110

Clinical Trials Clinical Trials Trials Compliance 110

pharmaphorum

JANUARY 25, 2021

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development. On the path to better product development.

Clinical Research 124

Clinical Research Research Clinical Trials Clinical Trials 124

Drug Discovery World

MARCH 7, 2023

DDW Editor Reece Armstrong takes a look at Qatar’s drug discovery and life sciences market, exploring how the country is utilising innovative technologies in its approach to healthcare. It also fits with the country’s preventative health approach that it established in its 2017-2022 Public Health Strategy 5.

Biobanking 52

Biobanking Drugs Genome Genomics 52

Intouch Solutions

DECEMBER 6, 2021

The Way Things Were The Way Things Are Assuming things can’t, or won’t, change Prepared to pivot Being satisfied with slow processes Agile processes that enable and encourage adaptation Raw data in siloes without context or meaning Predictive insights. It’s time to identify the trends that will shape 2022 and move to meet them.

Marketing 52

Marketing Branding Sales Clinical Trials 52

XTalks

OCTOBER 5, 2023

In an era marked by rapid technological advancements and transformative shifts in patient care, the healthcare industry continues to be a bastion of innovation and growth. Committed to fostering inclusivity, The Lactation Network is paving the way with progressive tech-enabled healthcare solutions.

Pharmacy 52

Pharmacy Life Science Engineer Gene 52

The Pharma Data

DECEMBER 9, 2020

Uniquely positioned in the rapidly evolving local biotech ecosystem in China in addition to an expansive global presence, Overland will strategically partner to jointly develop innovative, novel therapeutics. The creation of Overland isn’t the only exciting thing happening for international life sciences companies and organizations.

In-Vivo 52

In-Vivo In-Vitro Antibody Development 52

The Pharma Data

JANUARY 12, 2021

billion – – Recently announced acquisition agreement will enhance AstraZeneca’s presence in immunology and provides opportunity to expand on Alexion ‘s innovative complement-technology platforms – BOSTON –(BUSINESS WIRE)–Jan. 12, 2021– Alexion Pharmaceuticals, Inc. Morgan Healthcare Conference.

Containment 52

Containment Development Sales Production 52

The Pharma Data

JANUARY 26, 2021

BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. GRA delivers innovative, effective healthcare solutions through a range of pharmaceutical products and technology platforms.

Life Science 40

Life Science Production Marketing Dermatology 40

The Pharma Data

DECEMBER 12, 2020

Greater scientific presence in immunology by adding Alexion ‘s innovative complement-technology platforms and strong pipeline . Double-digit revenue growth through 2025; acquisition strengthens AstraZeneca’s broad-based revenue and the company will further globalise Alexion’s portfolio . ” Ludwig Hantson , Ph.D.,

Development 75

Development Regulation Medicine Containment 75